Telehealth GLP-1 prescriptions
A telehealth brand whose medical assessment is handled by OpenLoop Health, a network of US-licensed providers. It sells compounded GLP-1 injections and tablets and offers Zepbound, Wegovy and Ozempic for a membership fee plus the drug's own cost.
We may earn a commission if you buy through the links to MEDGm on this page, at no extra cost to you. That does not change how we grade or rank it, and MEDGm did not write or approve this review.
quality claims we could confirm ourselves, rather than repeat from the vendor's marketing.
Compounded GLP-1 injections, compounded GLP-1 tablets, and brand-name Zepbound, Wegovy and Ozempic via membership.
Everything here is a prescription service that starts with a licensed clinician's review of your own health information. Compounded medications are made by a pharmacy against a prescription and are not FDA-approved or reviewed by the FDA for safety, effectiveness or quality. This entry describes what the brand offers and what we could check. It is not medical advice and not a recommendation to use it.
Every telehealth brand we rank gets the same five checks, read from its public pages on September 24, 2026. "Not met" means we did not find it, or the terms say otherwise, on the pages we could read. Price and commission play no part.
Shows 'starting at' prices and a membership plus the cost of the drug for brand-name options.
Names OpenLoop Health as the prescriber network.
Refers to certified U.S. pharmacies without naming any.
Its refund policy says subscription fees are non-refundable, apart from medical disqualification.
No warning letter under this name in FDA's public database on September 24, 2026.
Graded by whether we could confirm it ourselves or are only repeating what the vendor states. A vendor's honesty about its own testing is a different question from what a published trial shows, so this is a separate scale from the evidence grades on our guides.
Both are 'starting at' prices on the GLP-1 page. The page does not show one flat monthly price per dose in the section we could read. We confirmed this ourselves.
Where the vendor states thisThe membership is $99 (Ozempic $171), and the drug is billed on top, so total monthly spend depends on the drug's own price, which the page does not fix. We confirmed this ourselves.
Where the vendor states thisThe site's disclosure says the assessment does not create a provider-patient relationship and that an OpenLoop Health clinician decides whether to prescribe. Near-identical wording appears on SnagRx and Embody, so treat it as a shared template.
Where the vendor states thisFDA does not review compounded drugs for safety, effectiveness or quality before they are sold. In 2026 FDA warned 30 telehealth companies over claims implying sameness with approved drugs, and proposed excluding semaglutide, tirzepatide and liraglutide from the 503B bulks list, so the legal footing of this category can change.
A $99 membership does not tell you what Zepbound or Wegovy will cost you each month.
Only weight loss is live, so the broader positioning is not yet backed by products.
OpenLoop Health, a network of US-licensed providers, decides whether to prescribe after you complete the assessment.
Every fact above traces to one of these pages, published by the vendor itself and checked on September 24, 2026. Vendor policy pages change without notice, so if something here looks out of date, it probably is.
Compare against
Open pricing, public COAs, strict research-only gate
